Short answer
Vera Therapeutics, Inc. (VERA) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results announced Feb 26, 2026: details in Exhibit 99.1 press release.
Vera Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results announced Feb 26, 2026: details in Exhibit 99.1 press release
- Filing covers fiscal year ended December 31, 2025
- "Furnished" (not "filed") status limits legal liability under Exchange Act Section 18
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Vera Therapeutics, Inc. 8-K filings
Get the next VERA 8-K as it lands
Follow VERA for push alerts, or ask the research agent what this filing means.